The brain computer interface market size was exhibited at USD 2.15 billion in 2024 and is projected to hit around USD 11.16 billion by 2034, growing at a CAGR of 17.9% during the forecast period 2024 to 2034.
| Report Coverage | Details |
| Market Size in 2025 | USD 2.53 Billion |
| Market Size by 2034 | USD 11.16 Billion |
| Growth Rate From 2024 to 2034 | CAGR of 17.9% |
| Base Year | 2024 |
| Forecast Period | 2024-2034 |
| Segments Covered | Product, Application, End use, Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional Covered | North America; Europe; Asia Pacific; Latin America; MEA |
| Key Companies Profiled | Medtronic; g.tec medical engineering GmbH; Natus Medical Incorporated; Compumedics Neuroscan; Brain Products GmbH; Integra LifeSciences Corporation; Advanced Brain Monitoring, Inc.; EMOTIV; NeuroSky; ANT Neuro; NIRx Medical Technologies, LLC; Ripple Neuro.; Neuroelectrics; OpenBCI; COGNIONICS, INC. (CGX); Blackrock Neurotech |
Key market drivers include the increasing prevalence of conditions requiring neuroprosthetics devices, the rising global geriatric population base, and technological developments facilitating communication and movement in paralytic patients.
Furthermore, the use of this technology in home control systems, virtual gaming, and military communication enhances the market's applicability, fueling its growth.
The increasing prevalence of neurodegenerative disorders is a significant driver of growth in the brain computer interface (BCI) market. Neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), and Multiple Sclerosis (MS), are characterized by the progressive degeneration of neurons, leading to a gradual loss of function in the affected areas of the brain and nervous system.
According to the WHO report, around 82 million people will be affected by dementia by 2030 and this number will reach 152 million by 2050. This shows the potential demand for BCI in the coming years. These conditions can severely impact an individual's motor functions, communication abilities, and overall quality of life. As the global population ages, the incidence of these disorders is expected to rise, creating a pressing need for innovative solutions that can help manage symptoms, restore lost functions, and improve the lives of affected individuals.
BCI technology offers a promising avenue for addressing the challenges posed by neurodegenerative disorders. By establishing a direct communication pathway between the brain and external devices, BCIs can bypass damaged neural pathways, enabling individuals to control devices, communicate, and interact with their environment in ways that would otherwise be impossible. For example, in cases of severe motor impairment, such as those caused by ALS, BCIs can provide a means for patients to communicate through text-to-speech systems or control assistive devices, such as wheelchairs or robotic arms. This capability not only enhances the autonomy and quality of life for individuals with neurodegenerative disorders but also reduces the burden on caregivers and healthcare systems.
Furthermore, growing awareness of the potential benefits of BCIs is also contributing to market growth. Advances in neuroscience and technology have led to a better understanding of how BCIs can be used to address specific challenges faced by individuals with neurodegenerative disorders. The launch of consumer-grade BCI devices, such as Neuralink's brain implant demonstration in August 2020, has further heightened public awareness and interest, creating a fertile ground for market growth.
The COVID-19 pandemic has significantly influenced the growth of the BCI market. The pandemic accelerated the adoption of telemedicine and remote monitoring technologies, increasing interest in BCIs for healthcare applications, particularly in aiding patients with neurological conditions. In addition, the focus on advancing medical technology for better patient outcomes during the pandemic has spurred investment in innovative BCI solutions.
However, supply chain disruptions and economic uncertainties have posed challenges, potentially delaying development and deployment. Overall, COVID-19 has highlighted the importance of BCI technologies in modern healthcare, fostering both opportunities and challenges for market growth.
The non-invasive BCI segment dominated the market with the largest revenue share of 85.94% in 2024, owing to the high applicability of this technology to products, such as headsets, amplifiers, and gaming sticks, contributing to the massive revenue generation. This system is considered to be the safest as the approach is less intrusive, which is further fueling the segment growth. In addition, numerous research projects are going on in this field. For instance, in June 2019 Carnegie Mellon University in collaboration with the University of Minnesota developed the first-ever mind-controlled robotic arm using BCI technology, which can track and follow a computer cursor.
The invasive segment is expected to witness lucrative growth over the forecast period. The growth in this area is driven by BCI technology's ability to provide functionality to paralyzed individuals through brain-controlled robotic limbs and restore vision by connecting the brain to an external camera. However, the invasive nature of these devices, implanted in the grey matter, can lead to scar tissue buildup. To address these challenges, market players are collaborating to develop advanced implantable BCIs. For example, in March 2024, Mass General Brigham Incorporated announced the formation of the Implantable Brain-Computer Interface Collaborative Community (iBCI-CC), the first collaborative community in clinical neurosciences to involve the U.S. FDA.
The healthcare segment held the highest market share in 2024, owing to the high applicability of this technology in the treatment of sleep disorders, neurological diseases, paralytic patients, and in studying neuroscience. Moreover, technological advancement & increasing initiatives by the key industry players are further fueling the market growth. For instance, in May 2024, CorTec received FDA approval for an investigational device exemption (IDE) application for its closed-loop brain-computer interface. This IDE permits the University of Washington School of Medicine to assess CorTec’s Brain Interchange implant system in a clinical study, focusing on a novel stroke rehabilitation treatment that utilizes cortical stimulation to promote brain plasticity.
The smart home control segment is projected to witness lucrative growth due to increased demand for a better lifestyle. With smart home controls, people are experiencing better convenience and comfort, from security monitoring to operating entertainment systems and appliances to maintaining connectivity. For instance, in March 2024, AAVAA introduced its new technology for integration with smart glasses. The BCI System for Smart Glasses aims to enhance device control across smart home applications, augmented reality (AR), virtual reality (VR), gaming, and assistive technologies, representing a significant advancement in accessibility and immersive experiences.
The medical segment dominated the market with the largest revenue share Of 48.0 in 2024. The growth is attributed to the application of BCIs in assisting disabled patients, including those with paralysis, epilepsy, Parkinson's, and Alzheimer's, to perform activities independently. BCIs enable the operation of wheelchairs, prosthetics, and other devices. Consequently, market players and universities are developing BCIs to meet these needs. For example, in August 2024, researchers from UC Berkeley and UC San Francisco developed a BCI that allows a woman with severe paralysis from a brainstem stroke to communicate using a digital avatar. This marks the first instance of synthesizing speech or facial expressions directly from brain signals. In addition, the system can decode these signals into text at nearly 80 words per minute, a significant improvement over existing technologies
The military segment is projected to experience significant growth over the forecast period, driven by its increased use in war activities. This includes the development of mobile robots equipped as weaponized drones and advanced communication systems, such as DARPA's "Silent Talk," which aims to enable telepathic command communication among soldiers. In addition, in 2018, DARPA launched a program to design a portable neural interface system capable of simultaneously interacting with multiple brain regions. The objective is to create a non-invasive brain-computer interface (BCI) for able-bodied service members by 2050, enhancing national security applications. This BCI could allow real-time thought communication between special forces soldiers and commanders, enabling immediate updates and quicker responses to threats.
North America brain computer interface market dominated the global market with the largest revenue share of 39.4% in 2024, primarily due to high R&D investments and a large number of clinical trials being conducted on brain devices in this region. In addition, the rising incidence of neurodegenerative conditions such as Parkinson's, Alzheimer's, and Huntington's disease in this region is expected to propel market growth. For instance, in 2022, the Alzheimer's Association reported a rise in the number of cases, highlighting the need for innovative solutions like BCIs to assist affected individuals. Moreover, the rising demand for immersive gaming is expected to lead to the development of technologies such as augmented brain-computer interfaces that further boost the adoption of BCI technology in this region.
U.S. Brain Computer Interface Market Trends
The brain computer interface market in the U.S. accounted for the largest share in 2024. One of the key factors driving the market growth is initiatives undertaken by market players and medical schools to advance BCIs and their applications. For instance, in March 2024, a team of neurosurgeons and neuroscientists from Mount Sinai's Icahn School of Medicine became the first in New York to investigate a new BCI designed to map extensive areas of the brain's surface in real-time, with a resolution hundreds of times greater than conventional arrays used in neurosurgical procedures.
Europe Brain Computer Interface Market Trends
The brain computer interface market in Europe is expected to grow significantly during the forecast period. This growth is driven by increasing strategic initiatives that promote adoption through various events. For example, in June 2024, ONWARD Medical N.V. will be featured in a keynote presentation at HLTH Europe, a leading event for digital health leaders. The company's CEO, along with a trial participant, will discuss the investigational ARC-BCI Therapy, which uses artificial intelligence to enable thought-driven movement after paralysis. The group will also explore the future of therapies for spinal cord injuries (SCI) and share the experience of Gert-Jan, the first person implanted with a brain-computer interface to restore walking.
The brain-computer interface market in the UK had a substantial share in 2024. The growth is attributed to the increasing participation by market players in various competitions that promote designing and developing BCI solutions. For instance, in December 2021, an Imperialstartup from London won the global BEETL AI Challenge for EEG Transfer Learning competition, sponsored by Facebook Reality Labs, for its brain-computer interface technology.
The France brain computer interface market is positively influenced by the increasing efforts to develop and adopt AI-based healthcare solutions. For instance, in May 2024, Allianz Trade and Inclusive Brains, a French startup specializing in generative AI-powered neural interfaces, partnered to develop Prometheus. This brain-machine interface converts neurophysiological data, including heart activity, brainwaves, eye movements, and facial expressions, into mental commands.
Asia Pacific Brain Computer Interface Market Trends
The brain computer interface market in the Asia Pacific region is expected to exhibit the highest growth over the forecast period. Significant untapped opportunities, increasing healthcare expenditure, and growing awareness amongst patients are expected to drive the demand for brain-computer interfaces in this region.
The brain-Computer Interface market in China is witnessing substantial growth, driven by advancements in neuroscience, artificial intelligence, and neurotechnology. The market is benefiting from the increasing adoption of BCI technologies in various sectors, including healthcare, gaming, and military applications. In healthcare, BCIs are being explored for their potential in treating neurological disorders, enhancing rehabilitation, and enabling communication for individuals with disabilities. For instance, in April 2024, China introduced its novel self-developed NeuCyber Array BMI System, a self-developed brain-machine interface from China, at the opening ceremony of the 2024 Zhongguancun Forum in Beijing.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the brain computer interface market
By Product
By Application
By End Use
By Regional
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers